De novo biosynthesis of τ-cadinol in engineered Escherichia coli
- PMID: 38647768
- PMCID: PMC10991332
- DOI: 10.1186/s40643-022-00521-7
De novo biosynthesis of τ-cadinol in engineered Escherichia coli
Abstract
τ-Cadinol is a sesquiterpene that is widely used in perfume, fine chemicals and medicines industry. In this study, we established a biosynthetic pathway for the first time in engineered Escherichia coli for production of τ-cadinol from simple carbon sources. Subsequently, we further improved the τ-cadinol production to 35.9 ± 4.3 mg/L by optimizing biosynthetic pathway and overproduction of rate-limiting enzyme IdI. Finally, the titer was increased to 133.5 ± 11.2 mg/L with a two-phase organic overlay-culture medium system. This study shows an efficient method for the biosynthesis of τ-cadinol in E. coli with the heterologous hybrid MVA pathway.
Keywords: Escherichia coli; MVA; Metabolic engineering; τ-Cadinol.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
Grants and funding
LinkOut - more resources
Full Text Sources
